PFIZER INC CEDEAR EACH 4 REP 1 (PFE.BA) Financials
PFE.BA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 226.5 billion | 137.2 billion |
| 2023-09-30 | 215.0 billion | 117.8 billion |
| 2023-06-30 | 220.2 billion | 120.9 billion |
| 2023-03-31 | 195.6 billion | 94.4 billion |
PFE.BA Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 4.2 billion | 121.0 million |
| 2023-09-30 | 2.6 billion | 151.0 million |
| 2023-06-30 | -2.1 billion | 148.0 million |
| 2023-03-31 | 73.0 million | 105.0 million |
PFE.BA Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | -3.4 billion |
| 2023-09-30 | -2.4 billion |
| 2023-06-30 | 2.3 billion |
| 2023-03-31 | 5.5 billion |
PFE.BA Cash and Debt
No data available :(
PFE.BA Shares Outstanding
PFE.BA Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1.0 billion | 2.8 billion | 4.6 billion | - |
| 2023-09-30 | 810.0 million | 2.7 billion | 3.3 billion | - |
| 2023-06-30 | 914.0 million | 2.6 billion | 3.5 billion | - |
| 2023-03-31 | 914.0 million | 2.5 billion | 3.4 billion | - |
PFE.BA Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 14.2 billion | 7.6 billion |
| 2023-09-30 | 13.2 billion | 9.3 billion |
| 2023-06-30 | 12.7 billion | 3.2 billion |
| 2023-03-31 | 18.3 billion | 4.9 billion |
PFE.BA
Price: ARS8,840
Dividend Yield: 0.00%
Forward Dividend Yield: 2.13%
Payout Ratio: 0.03%
Dividend Per Share: 0.21 ARS
Earnings Per Share: -88.54 ARS
P/E Ratio: 13.83
Exchange: BUE
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 145.2 trillion
Average Dividend Frequency: 4
Years Paying Dividends: 16
DGR3: -19.12%
DGR5: 3.53%
DGR10: 23.68%